Sign In
Buy FOLD
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Enphase Energy Welcomes the Members of Amicus Solar Cooperative
12:00pm, Monday, 16'th Mar 2020
Enphase Energy, Inc. (ENPH), a global energy technology company and the world’s leading supplier of solar microinverters, today announced that the Company has forged an alliance with Amicus Solar Co
The Coronavirus Market Survival Guide
10:16am, Monday, 16'th Mar 2020
Markets just had their most tumultuous week of trading since the financial crisis of 2008. By the end of the week, extraordinary measures had been put in place
144 Biggest Movers From Friday
09:03am, Monday, 16'th Mar 2020
Gainers
Contura Energy, Inc. (NYSE: CTRA) shares surged 64.7% to close at $4.89 on Friday. Contura is expected to release Q4 results on March 18.
Exterran Corporation (NYSE: EXTN...
Bank of Montreal Can Purchases 70,868 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
08:52am, Sunday, 15'th Mar 2020
Bank of Montreal Can boosted its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 314.5% in the fourth quarter, according to the company in its most recent disclosure with the Securiti
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Rating of "Buy" from Analysts
07:42am, Sunday, 15'th Mar 2020
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) have been given a consensus recommendation of “Buy” by the nine ratings firms that are currently covering the company, MarketBeat reports. Two equ
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Amicus Therapeutics (NASDAQ:FOLD) Trading Down 11.9% Following Insider Selling
06:32am, Wednesday, 11'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) traded down 11.9% during trading on Monday following insider selling activity. The company traded as low as $8.35 and last traded at $8.36, 3,213,353 shares tra
With the Market Down, I'm Buying These 3 Stocks
03:18pm, Tuesday, 10'th Mar 2020
Amicus Therapeutics, Amarin, and CRISPR Therapeutics are all way oversold.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) COO Bradley L. Campbell Sells 2,500 Shares
08:46am, Tuesday, 10'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) COO Bradley L. Campbell sold 2,500 shares of Amicus Therapeutics stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $10.
Cowen & Co. Maintains a Buy Rating on Amicus (FOLD)
11:56pm, Monday, 09'th Mar 2020
In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Amicus (FOLD), with a price target of $31.00. The company's shares
Cowen & Co. Maintains a Buy Rating on Amicus (FOLD)
11:56pm, Monday, 09'th Mar 2020
In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Amicus (FOLD – Research
Fmr LLC Sells 978,347 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
08:44am, Monday, 09'th Mar 2020
Fmr LLC trimmed its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 34.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
FY2020 Earnings Estimate for Amicus Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:FOLD)
06:42am, Monday, 09'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) – Equities research analysts at Cantor Fitzgerald decreased their FY2020 EPS estimates for Amicus Therapeutics in a research note issued on Thursday, March 5t
